Genetic variation in the INMT gene strongly impacts the production of trimethylsulfonium in humans
We previously identified the trimethylsulfonium ion (TMS) in human urine and highlighted its potential as a novel H<sub>2</sub>S biomarker but observed significant inter-individual variability in its urinary excretion. In this work we investigate the contribution of genetic factors to this variability in a group of European subjects (n = 100) from the BioPersMed cohort. Urinary TMS concentrations displayed two clusters within 5.0-20 nM and 100-400 nM. Genotyping revealed that this clustering is linked to a single nucleotide polymorphism (rs6970396) in the INMT gene, P < 0.001. We found strong contrast in the effects of rs6970396 between TMS and the selenium analogue TMSe which is one of many other detoxification products of the poorly recognized chalcogen-methylation activity of the INMT enzyme. Genetic variability in INMT has wide implications not only for the detoxification of H<sub>2</sub>S, both inhaled and naturally produced, but also for that of other volatile sulfur compounds in humans which may serve as substrates including xenobiotics.
Authors
- Christoph Haudum (ORCID: https://orcid.org/0000-0002-3872-5643)
- Olivia Trummer
- Walter Goessler (ORCID: https://orcid.org/0000-0002-0142-9373)
- Bassam Lajin (ORCID: https://orcid.org/0000-0002-7501-0014)
- Barbara Obermayer‐Pietsch (ORCID: https://orcid.org/0000-0003-3543-1807)
- Cornelia Missbrenner
- Carina Maria Laglstorfer
Institutions
- University of Graz (AT)
- Medical University of Graz (AT)
- BioTechMed-Graz (AT)
Publication Details
- Journal
- Environmental Toxicology and Pharmacology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1016/j.etap.2025.104662
- Citations
- 1
- Primary Topic
- Sulfur Compounds in Biology
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Austrian Science Fund